BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260714T170000
DTEND;TZID=Australia/Sydney:20260714T170000
DTSTAMP:20260614T164221
CREATED:20260505T055930Z
LAST-MODIFIED:20260505T055930Z
UID:10000291-1784048400-1784048400@melanoma.org.au
SUMMARY:MRFF National Critical Research Infrastructure
DESCRIPTION:The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. \nStream 1 – Innovation enablers\nAddress an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks\, tissue repositories\, novel platforms\, and secure health data environments to create valuable research resources. \nStream 2 – Digitisation of health care\nTranslate or implement innovative artificial intelligence technologies into health applications that: \n\nbenefit multiple health disciplines/areas\ninvolve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and\nincrease artificial intelligence workforce capacity and capability\, particularly in relation to health\, through cross-sector and interdisciplinary collaboration.\n\nStream 3 – Co-investment partnerships\nUtilise co-investment (cash only) with the research sector\, state and/or territory governments\, and industry\, in significant critical research infrastructure (e.g. facilities\, personnel and equipment): \n\nto support development of research capacity\, capability and/or effectiveness in an area of unmet medical need\, or\nto enable Australian research using new platforms\, systems and services in an area of unmet medical need.\n\nStream 4 – mRNA technology enablers\nLeverage and enhance emerging mRNA technologies\, platforms\, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need. \nGrants to fund research infrastructure projects\, up to $3 million in Streams 1\, 2 and 4\, and up to $7 million in Stream 3. \nAn application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application. \n\n\n\nKey Dates\nApplications close: 14 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-research-infrastructure/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Critical-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260614T164221
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260916T170000
DTEND;TZID=Australia/Sydney:20260916T170000
DTSTAMP:20260614T164221
CREATED:20260602T045957Z
LAST-MODIFIED:20260602T045957Z
UID:10000300-1789578000-1789578000@melanoma.org.au
SUMMARY:MRFF International Clinical Trial Collaborations
DESCRIPTION:The objective of the Medical Research Future Fund (MRFF) – 2026 International Clinical Trial Collaborations Grant Opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \n\nPromote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.\nProvide high-quality evidence of the effectiveness of novel health treatments\, drugs or devices in ‘usual care’ settings\, which will support a decision on whether to deliver the intervention in an Australian setting.\n\nThe anticipated outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality\, evidence-based and effective health care. \nPlease note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only. \n\nKey Dates:\nMinimum data due: 19 August 2026\nApplications close: 16 September 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-int-clinical-trial-collaborations/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-International-Clinical-Trial-Collaborations-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR